Jupiter Neurosciences, Inc. (JUNS) NASDAQ
0.37
-0.011(-2.90%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 34.72M |
| Enterprise Value | 36.25M |
| P/E Ratio | -1.65 |
| PEG Ratio | 0.05 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -6.85 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.88 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -1.37 |
| Return On Equity | -11.55 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | 0 |
| Net Income | 0 |
| Diluted EPS | 0 |
Balance Sheet
| Total Cash | 3.79M |
| Total Cash/Share | 0.11 |
| Total Debt | 5.32M |
| Total Debt/Equity | -2.9 |
| Current Ratio | 0.65 |
| Book Value Per Share | -0.05 |
Price History
| 52-Week Change | -42.3 |
| 52-Week High | 3.33 |
| 52-Week Low | 0.31 |
| Moving Average 50 Days | 0.52 |
| Moving Average 200 Days | 1.15 |
Statistics
| Average Volume | 322,454 |
| Shares Outstanding | 34.43M |
| % Held by Institutions | 1.88 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
